MedPath

ActivX Biosciences, Inc.

🇺🇸United States
Ownership
Subsidiary
Established
2000-01-01
Employees
11
Market Cap
-
Website
http://www.activx.com

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone

Phase 2
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
First Posted Date
2009-10-15
Last Posted Date
2014-06-26
Lead Sponsor
ActivX Biosciences, Inc.
Target Recruit Count
403
Registration Number
NCT00995345

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

Phase 2
Completed
Conditions
Type 2 Diabetes
First Posted Date
2007-09-05
Last Posted Date
2013-08-22
Lead Sponsor
ActivX Biosciences, Inc.
Target Recruit Count
213
Registration Number
NCT00525330
© Copyright 2025. All Rights Reserved by MedPath